Manufacturing

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Articles

The freedom of design found in additive manufacturing offers the potential for improved processing equipment, both in prototypes and commercial equipment.

Producing Bio/Pharma Equipment Using 3D Printing

The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.

FUJIFILM Invests in New Continuous Processing Facility

Sartorius Stedim Biotech’s Generation 2 ambr 15 cell culture microbioreactor system offers increased flexibility and expanded capability for clone selection, media and feed optimization, and early process development work. 

Microbioreactor System

The Vaccine Development and Bioprocess Cell Culture Technology Day will take place on May 16, 2019 in Baltimore, MD.

Eppendorf Hosts Vaccine Development and Bioprocess Cell Culture Technology Day

Large biopharmas, emerging biotechs, and CMOs are looking for novel ways to improve the productivity of biologics in a rapidly evolving biotherapeutics market.

The Search for Bioprocess Productivity Improvement

The BioContinuum Buffer Delivery Platform offers streamlined buffer management and delivers “contiGuous” bioprocessing.

MilliporeSigma Unveils Buffer Delivery Component for BioContinuum Platform at INTERPHEX 2019

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

The company has launched a comprehensive portfolio of custom cell biology solutions and a new cell-line engineering technology.

Lonza Strengthens Cell Capabilities

Distek, a provider of laboratory testing instruments, added a dual impeller single-use bioreactor (SUB) system to its BIOne portfolio.

Dual Impeller Single-Use Bioreactor

The $21.4-billion acquisition will create stand-alone business within Danaher’s life-sciences portfolio.

Manufacturing Equipment, Upstream Processing